VISTAGEN THERAPEUTICS INC (VTGN)

US92840H4002 - Common Stock

4.72  -0.11 (-2.28%)

Premarket: 4.81 +0.09 (+1.91%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-12-31)
2023
(2023-3-31)
2022
(2022-3-31)
2021
(2021-3-31)
2020
(2020-3-31)
Revenue
1.05M-230.00K1.11M1.09M0.00
Gross Profit
N/AN/A1.11M1.09MN/A
Operating Expenses
34.95M59.04M48.89M19.02M20.80M
Research and Development
21.87M44.28M35.31M12.41M13.33M
Selling, General, and Administrative Expenses
13.03M14.66M13.48M6.55M7.43M
Operating Income
-33.90M-59.27M-47.78M-17.93M-20.80M
Interest Income/Expense
1.83M30.00K20.00K0.0030.00K
Other Income/Expense
N/AN/A0.000.00N/A
Non Recurring Items
N/AN/AN/AN/A0.00
Income Before Taxes
-32.07M-59.24M-47.76M-17.93M-20.77M
Income Tax
0.0010.00K0.000.000.00
Net Income
-32.07M-59.25M-48.71M-42.32M-22.04M
EBITDA
-33.78M-59.14M-47.63M-17.81M-20.70M
 
Per Share Data
EPS Diluted Total Ops
-3.58-8.51-7.38-14.74-15.09
Non GAAP EPS
N/A-8.65-2.86-0.39-0.50
 
Statistics
Gross Profit Margin
N/AN/A100.00%100.00%N/A
Profit Margin
-3050.20%25760.87%-4388.29%-3882.57%N/A
Operating Profit Margin
-3224.65%25769.57%-4304.50%-1644.95%N/A

All data in USD

Charts